Related Experiment Video
Updated: Aug 5, 2025
Modeling Spontaneous Metastatic Renal Cell Carcinoma mRCC in Mice Following Nephrectomy
Published on: April 29, 2014
Surgical Approach in Metastatic Renal Cell Carcinoma: A Literature Review
Milena Matuszczak1, Adam Kiljańczyk1, Maciej Salagierski1
1Department of Urology, Collegium Medicum, University of Zielona Góra, 65-046 Zielona Góra, Poland.
Surgery, including cytoreductive nephrectomy and metastasectomy, plays a role in treating metastatic kidney cancer with limited spread. Optimal treatment choices for metastatic renal cell carcinoma continue to be debated.
Area of Science:
- Oncology
- Surgical Oncology
Background:
- Metastatic renal cell carcinoma (mRCC) treatment has evolved significantly over the past 20 years.
- Cytoreductive surgery remains a consideration for select mRCC patients.
Purpose of the Study:
- To summarize the current surgical management strategies for metastatic kidney cancer.
- To discuss the role of cytoreductive nephrectomy and metastasectomy in mRCC.
Main Methods:
- Review of current literature and treatment guidelines.
- Analysis of the indications and outcomes of surgical interventions in mRCC.
Main Results:
- Cytoreductive nephrectomy and metastasectomy are beneficial in patients with a limited metastatic burden.
- Surgery can be part of a multimodal approach in managing mRCC.
Conclusions:
- Surgery retains a defined role in the multidisciplinary treatment of metastatic renal cell carcinoma.
- The optimal treatment strategy for mRCC, balancing surgery and systemic therapies, requires careful consideration.
More Related Videos
06:38A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies
Published on: April 12, 2017
05:36Comparing Metastatic Clear Cell Renal Cell Carcinoma Model Established in Mouse Kidney and on Chicken Chorioallantoic Membrane
Published on: February 8, 2020